GoodRx Holdings, Inc. (NASDAQ:GDRX) Short Interest Update

GoodRx Holdings, Inc. (NASDAQ:GDRX) saw a large decrease in short interest during the month of March. As of March 13th, there was short interest totaling 9,212,055 shares, a decrease of 15.8% from the February 26th total of 10,935,571 shares. Based on an average daily volume of 4,115,761 shares, the days-to-cover ratio is currently 2.2 days. Approximately 2.8% of the company’s stock are sold short.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. LSV Asset Management raised its position in shares of GoodRx by 517.1% during the third quarter. LSV Asset Management now owns 2,354,581 shares of the company’s stock valued at $9,960,000 after buying an additional 1,973,017 shares during the last quarter. Prescott Group Capital Management L.L.C. acquired a new stake in GoodRx during the fourth quarter worth about $4,812,000. Northwestern Mutual Wealth Management Co. increased its stake in GoodRx by 10,242.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,502,666 shares of the company’s stock valued at $4,072,000 after acquiring an additional 1,488,137 shares during the period. Pacer Advisors Inc. bought a new stake in shares of GoodRx in the 3rd quarter worth approximately $3,687,000. Finally, AQR Capital Management LLC grew its holdings in shares of GoodRx by 188.0% during the 4th quarter. AQR Capital Management LLC now owns 1,158,546 shares of the company’s stock worth $3,140,000 after purchasing an additional 756,209 shares in the last quarter. Institutional investors own 63.77% of the company’s stock.

GoodRx Stock Performance

GoodRx stock opened at $1.94 on Monday. GoodRx has a 52 week low of $1.77 and a 52 week high of $5.81. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.61 and a current ratio of 2.61. The firm has a market capitalization of $664.59 million, a PE ratio of 21.56, a PEG ratio of 1.34 and a beta of 1.52. The business’s 50-day simple moving average is $2.27 and its 200-day simple moving average is $2.96.

GoodRx (NASDAQ:GDRX) last released its earnings results on Wednesday, February 25th. The company reported $0.09 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.09. GoodRx had a return on equity of 9.31% and a net margin of 3.82%.The firm had revenue of $194.79 million for the quarter, compared to analyst estimates of $193.27 million. During the same quarter last year, the firm posted $0.09 EPS. The company’s revenue was down 1.9% on a year-over-year basis. Equities research analysts forecast that GoodRx will post 0.13 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on GDRX. JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of GoodRx in a research note on Friday, February 27th. Weiss Ratings reissued a “sell (d)” rating on shares of GoodRx in a research report on Tuesday, December 23rd. Wall Street Zen lowered GoodRx from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Mizuho reduced their price target on GoodRx from $4.00 to $3.00 and set a “neutral” rating for the company in a research report on Friday, February 27th. Finally, Citigroup lowered their price objective on GoodRx from $4.50 to $3.50 and set a “buy” rating on the stock in a report on Tuesday, March 3rd. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $3.98.

GoodRx Company Profile

GoodRx Holdings, Inc (NASDAQ: GDRX) operates a digital healthcare platform designed to help consumers compare prescription drug prices at retail pharmacies across the United States. Through its website and mobile applications, GoodRx aggregates pricing and discount information from a wide network of pharmacies, enabling users to access coupons and savings programs on both generic and brand-name medications. The platform also features price transparency tools that inform patients about cost variations and available discounts to alleviate the financial burden of prescription medications.

In addition to its core drug pricing service, GoodRx offers telehealth services under the GoodRx Care brand, providing virtual consultations for a range of non-emergency conditions and prescription needs.